Who They Are
AliveCor, Inc. is pioneering the creation of FDA-cleared ‘machine learning’ techniques to enable proactive heart care and is recognized around the world for transforming cardiac care. The FDA-cleared Kardia Mobile is the most clinically validated mobile EKG solution on the market and is recommended by leading cardiologists and used by people worldwide for accurate EKG recordings. This simple to use mobile device and app-based service provides instant analysis for detecting atrial fibrillation (AF) and normal sinus rhythm in an EKG. AliveCor was recognized as a 2015 Tech Pioneer by the World Economic Forum and one of the 50 Smartest Companies in 2015 by the MIT Technology Review (#14). AliveCor is a privately-held company headquartered in San Francisco.
How We Helped
Square 1 started working with AliveCor in early 2015. At the time, AliveCor had great technology and many pathways to success but the company’s investors were still in search of the right team to bring a vision and a plan to the Company. And as a complex, cutting edge business, AliveCor needed a banking partner with knowledge and determination to match its vision.
Square 1 was able to put a term loan in place that provided AliveCor and its investors with the time they needed to find the perfect CEO and raise the equity they needed to support that CEO’s vision. Along the way AliveCor continued to develop world-class technology and when bumps in the road arose, Square 1 was able to work with Khosla Ventures and the other investors to manage around them. Toward the end of 2015, the investors found an exceptional CEO for AliveCor in Vic Gundotra.
Each client’s story and path is unique. Square 1 client case studies, testimonials and stories give insight into select client successes and the potential benefits of a Square 1-client relationship. These representative examples should not be viewed as an assurance or guarantee of a particular outcome. Results vary significantly based on market dynamics, user efforts and many other circumstances.